Edge Wealth Management LLC reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 23.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 134,528 shares of the company’s stock after selling 41,004 shares during the period. Edge Wealth Management LLC’s holdings […]
Artia Global Partners LP raised its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 422.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 824,363 shares of the company’s stock after acquiring an additional 666,600 shares during the […]
Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $16.00 to $15.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts also recently weighed in on ROIV. Truist Financial reissued a buy rating and […]
Roivant Sciences (ROIV) Set to Announce Quarterly Earnings on Monday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Roivant Sciences (NASDAQ:ROIV – Get Free Report) and LifeVantage (NASDAQ:LFVN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk. Risk and Volatility Roivant Sciences has a beta of […]